Literature DB >> 26963552

The changing life science patent landscape.

Arti K Rai1, Jacob S Sherkow2.   

Abstract

Mesh：

Year:  2016        PMID： 26963552     DOI： 10.1038/nbt.3504

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

1.  Comment: compulsory licensing of patented pharmaceutical inventions: evaluating the options.

Authors:  Jerome H Reichman
Journal:  J Law Med Ethics       Date:  2009       Impact factor: 1.718

2.  Drug Development. Are trade secrets delaying biosimilars?

Authors:  W Nicholson Price; Arti K Rai
Journal:  Science       Date:  2015-04-09       Impact factor: 47.728

3.  The Trans-Pacific Partnership--Is It Bad for Your Health?

Authors:  Amy Kapczynski
Journal:  N Engl J Med       Date:  2015-06-10       Impact factor: 91.245

4.  FDA regulation of laboratory-developed diagnostic tests: protect the public, advance the science.

Authors:  Joshua Sharfstein
Journal:  JAMA       Date:  2015-02-17       Impact factor: 56.272

5.  Intellectual property. Drug patents at the Supreme Court.

Authors:  C Scott Hemphill; Bhaven Sampat
Journal:  Science       Date:  2013-03-22       Impact factor: 47.728

Review 6.  Can patents deter innovation? The anticommons in biomedical research.

Authors:  M A Heller; R S Eisenberg
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

7.  Does generic entry always increase consumer welfare?

Authors:  Henry Grabowski; Tracy Lewis; Rahul Guha; Zoya Ivanova; Maria Salgado; Sally Woodhouse
Journal:  Food Drug Law J       Date:  2012       Impact factor: 0.619

8.  The dangers of diagnostic monopolies.

Authors:  Robert Cook-Deegan; Subhashini Chandrasekharan; Misha Angrist
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

9.  The next controversy in genetic testing: clinical data as trade secrets?

Authors:  Robert Cook-Deegan; John M Conley; James P Evans; Daniel Vorhaus
Journal:  Eur J Hum Genet       Date:  2012-11-14       Impact factor: 4.246
  9 in total
  5 in total

1.  The Bermuda Triangle: The Pragmatics, Policies, and Principles for Data Sharing in the History of the Human Genome Project.

Authors:  Kathryn Maxson Jones; Rachel A Ankeny; Robert Cook-Deegan
Journal:  J Hist Biol       Date:  2018-12       Impact factor: 1.326

2.  Drafting eligible biotech and immunotherapy claims.

Authors:  Shyh-Jen Wang
Journal:  Hum Vaccin Immunother       Date:  2019-05-22       Impact factor: 3.452

3.  Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?

Authors:  Mateo Aboy; Cristina Crespo; Kathleen Liddell; Johnathon Liddicoat; Matthew Jordan
Journal:  Nat Biotechnol       Date:  2018-12-06       Impact factor: 54.908

4.  After Myriad, what makes a gene patent claim 'markedly different' from nature?

Authors:  Mateo Aboy; Johnathon Liddicoat; Kathleen Liddell; Matthew Jordan; Cristina Crespo
Journal:  Nat Biotechnol       Date:  2017-09-11       Impact factor: 54.908

Review 5.  Orthogonal Drug Pooling Enhances Phenotype-Based Discovery of Ocular Antiangiogenic Drugs in Zebrafish Larvae.

Authors:  Nils Ohnesorge; Temitope Sasore; Daniel Hillary; Yolanda Alvarez; Michelle Carey; Breandán N Kennedy
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.